Hillary joined KHI as in Intern in 2008 assisting the discovery team with research and various projects. She returned as a full time recruiter in 2011 and has since helped grow the bioprocess development and manufacturing practice.
Hillary partners with organizations ranging from VC backed start-ups and mid-size biotechs to large multinational biopharma companies in helping to identify individuals working exclusively in biologics/large molecule development. These scientific and operational leaders tend to be formally trained in Chemical/Biomolecular Engineering and are tasked with bridging the gap between R&D and development and readying products for manufacturing and launch.
While at KHI, Hillary has been instrumental in honing her business to partner with clients developing emerging technology in the fields of cell and gene therapy, regenerative medicine, and stem cells. In addition, Hillary works around more traditional commercialized products such as vaccines, monoclonal antibodies, and other therapeutic proteins. She has also expanded into analytical leadership opportunities still keeping a niche focus on the areas listed above.
Prior to KHI, Hillary attended the Fox School of Business, Temple University in Philadelphia, PA where she earned a BBA in Marketing.